DIAGNOSTIC TEST CAB-CF COGNITIVE CHEMO FOG · The CAB-CF is a scientiAc resource that makes it possible to evaluate the risk index of suffering from Chemo-Fog effect during the oncology

JEFF WALKERDATE OF ASSESSMENT: 01/02/18BIRTHDAY: 15/07/62AGE: 55

COGNITIVE CHEMO FOGDIAGNOSTIC TEST CAB-CFRESULTS REPORT

Cognitive risks

PhysicalS ym ptom s

Em otionalS ym ptom s

S ym ptom s of Chem o-Fog

JEFF'S PROFILE

LOW RIS K MODERATE RIS K HIGH RIS K

PURCHASE THIS ASSESSMENT

https://www.cognifit.com/cognifit/assessment/index/a/quimioneblina-assessment/l/en

Cognit ive Chemo Fog Diagnost ic Test CAB-CF 2

* T his assessment is not a diagnostic test, but rather a tool to help detect and assess the risk of having physical,psychological and cognitive symptoms associated with the Chemo-Fog effect.

MODERATE RISK OF CHEMO-FOG EFFECTJeff Walker's Results

SYMPTOMS

11/21

A moderate risk has beendetected, possibly associatedwith the Chemo-Fog effect .No apparent risk range: 0-7Symptoms detected: 11

COGNITIVE RISKS

1 /7

No signif icant risk associatedwith the Chemo-Fog effect hasbeen detected.No apparent risk range: 0-2Detected risks: 1

ASSESSMENT

EVALUATED RISKS AND SYMPTOMS NO APPARENT RISK JEFF

Physical symptoms 0-2 1

Emotional symptoms 0-1 1

Symptoms of chemo-fog 0-4 9

Cognitive risks 0-2 1

We recommend clarifying what causes the symptoms shown in Jeff since you haveresponded to exclusion criteria that may be incompatible with the Chemo-Fogeffect.

Use this code to get a 25% on the clinical brain training program: Chemo -Fo g

CONCLUSIONS

Purchas e this as s es s ment



00CHEMO FOG ASSESSMENTDESCRIPTIONJeff, 55 years o ld, took the cognitive assessment for cancer patients "Chemo-Fog" on 01/02/18 .The initial questionnaire adapts to the criteria, signs, and symptoms of the Chemo-Fog effect.The cognitive scores are evaluated based on clinical scales and on normalized, validated testsfor 55 years of age.

T he CogniFit Computerized Chemo-Fog Evaluation (CAB-CF) consist s of a se rie s of clin ica lque st ions a nd a se t of pra ct ica l t a sks wit h a t ot a l dura t ion of a bout 30-40 m inut e s.T he CAB-CF is a scienti c resource that makes it possible to evaluate the risk index of sufferingfrom Chemo-Fog effect during the oncology process, evaluating the main neuropsychologicalfactors identified in the scientific literature for this disorder.

T he results presented in this report are a re ection of the user's performance on a speci c dayand at a speci c time. User performance may vary depending on the time of day, level ofcomfort, alertness, and a number of other factors. T he results and data in this report do notre ect a diagnosis and should be reviewed and interpreted by a quali ed healthcare professional(psychologist, psychiatrist, neurologist, etc.) and should be used as a complement to a clinicalconsultation.

T he results from this assessment offer a base on which to identify support strategies or to getprofessional help. T his cognitive screening is designed to provide valuable information to helpobjectively assess the different neuropsychological factors of those people who are suspectedof cognitive decline after the cancer process.

01SYMPTOMST he answers from the questionnairewill be focused on the followingareas:

Physical SymptomsEmotional SymptomsSymptoms of Chemo-Fog

02COGNITIVE RISKSIn this section, you will see a circulardiagram next to each evaluated area,which will indicate the user's scorebased on their percentile andnormalized for their age and gender.For example, a score of 500 would becalculated depending on the user'sage group. CogniFit's values arecalculated in percentiles but areshown adjusted on a scale of 0-800.As such, the higher score, the better.

Gre e n : Cognitive strengthsYe llow: Below-average cognitiveskillsRe d : Cognitive weaknesses

03CONCLUSIONSAt the end of the report, you will find:

A description of the risk index andthe effects on cognitive pro leand detected symptoms.Speci c recommendations andpersonalized plan of action.

THE CAB-CF REPORT IS MADE UP OF THREE PARTS:




01 SYMPTOMSOvercoming a cancer process entails a series of consequences that we can group together indifferent areas such as the emotional, physical and cognitive areas. A large number of patientsverbalize that they have trouble concentrating, forget more frequently, they can't think clearly orhave lack of clarity. This cognitive decline can be caused by many factors: age, gender,medication, emotional stress, anxiety, and cancer type. Pioneering studies in this area arecurrently underway since cancer survival patients are increasing and side effects to the cancerprocess become evident after recovery.

JEFF'S SYMPTOMSSHOW A MODERATERISK FOR THECHEMO-FOG EFFECT

1/5

PHYSICAL SYMPTOMSLOW RIS KBoth cancer treatm ent, the disease itse lf andhospitalization entail physical, digestive , m etabolic ,m otor, altered sleep patterns or changes in one 's ownim age that can affect to a greater or lesser extent thepatient who has undergone an oncological process.

1/4

EMOTIONAL SYMPTOMSLOW RIS KCancer diagnosis and disease developm ent generateconsiderable psychological distress in patients and the irfam ilies. S tudies show that 25% to 50% of patientsdiagnosed with cancer experience e levated leve ls ofem otional distress. Recent research shows that sym ptom sof depression, anxiety and em otional distress in cancerpatients is m ore com m on than in the general population.

9/12

SYMPTOMS OF CHEMO-FOGHIGH RIS KThis term is used to describe changes in m em ory,attention, concentration, and ability to perform variousm ental tasks assoc iated with receiving chem otherapy andhorm one therapy treatm ents for cancer. In these cognitivedefic its, there are other factors besides m edication, suchas age , gender or type of cancer.




MODERAT E RISK

JEFF'S COMPLETE SYMPTOMREPORT

According to the results of the questionnaire, Jef f shows important symptoms ofchemo- fog. Therefore, there are symptoms compatible with a decline or decrease incognitive performance and other possibilities should not be ruled out. It isrecommended that this information be provided to a professional to assist in anaccurate diagnosis.

IMPORT ANT These results are not a diagnosis. This information cannot substitute a formaldiagnosis given by a professional, but it can serve as a complementary tool to help make acomprehensive diagnosis.

JEFF'S PROFILE


Physical Symptoms

Emotional SymptomsSymptoms of Chemo-Fog




PHYSICAL SYMPTOMSLOW RISKJeff has no physical symptoms. Both cancer treatment, the disease itself and hospitalization entailphysical, digestive, metabolic, motor, altered sleep patterns or changes in one's own image that can affectto a greater or lesser extent the patient who has undergone an oncological process.

EMOTIONAL SYMPTOMSLOW RISKJeff has no emotional symptoms. Cancer diagnosis and disease development generate considerablepsychological distress in patients and their families. Studies show that 25% to 50% of patients diagnosedwith cancer experience elevated levels of emotional distress.

IN DETAIL: SYMPTOMS ASSOCIATED WITH THECHEMO-FOG EFFECT




SYMPTOMS OF CHEMO-FOGHIGH RISKJeff has warning symptoms of decline or decrease in cognitive performance compatible with Chemo-Fogeffect. T his term is used to describe changes in memory, attention, concentration, and ability to performvarious mental tasks that are associated with receiving chemotherapy, hormone therapy treatments andother factors such as age, type of cancer, or gender.

The answers from the questionnaire that indicate that Jeff has a high risk of cognitive decline are:Has trouble remembering the names of things (people, objects, places) than before.Makes mistakes that they didn't make before.Has more trouble planning and organizing their time than before.Has trouble concentrating on reading a book or watching a movie.Needs their day planner more than ever to remember events and appointments.Feels slower when doing any activity.Always feels mentally exhausted.After cancer treatment, they've seen changes in memory, language, or concentration skills.Friends, family, or people close to them say that they're "easily distracted".




02COGNITIVE RISKSIn this section, you will see a circular diagram next to each evaluated area, which will indicate theuser's score based on their percentile and normalized for their age and gender. For example, ascore of 500 would be calculated depending on the user's age group. CogniFit's values arecalculated in percentiles but are shown adjusted on a scale of 0-800. As such, the higher score,the better.

NO RISK WASDETECTED IN JEFF'SCOGNITIVE PROFILE

REASONING

642/800Ability to effic iently use (organize , re late , e tc .)acquired inform ation.

MEMORY

366/800Ability to retain and m anipulate new inform ationand recover past m em ories.

ATTENTION

576/800The ability to filter distractions and concentrate onre levant inform ation.

COORDINATION

520/800The ability to effic iently and prec ise ly carry outorganized m ovem ents.

PERCEPTION

296/800Ability to interpret stim uli from the environm ent.




LOW RISK

COMPLETE COGNITIVE REPORTFOR JEFF

No risk was found in Jef f 's cognitive prof ile. The results f rom the dif ferent tasks in thecognitive assessment highlight that Jef f 's cognitive strengths are reasoning, attentionand coordination, while memory and perception are areas of improvement. As such,Jef f 's cognitive pattern does not show any cognitive weaknesses consistent with adecline or decrease in cognitive performance (Chemo- Fog ef fect). We recommendthat you provide this information to a professional in order to make a more precisediagnosis.


JEFF'S PROFILE


Reasoning

Memory

AttentionCoordination

Perception




642/800

PLANNING Score Received: 642

Jeff has obtained a score in planning appropriate for their age, so it is not an indicatorof cognitive decline. Planning is the ability to organize mentally the best way to achievea goal in the future, such as when we organize a story in our head to tell later. Changesin planning are described in the Chemo-Fog effect. Planning di culties pose problemsin structuring thinking, ideas, day-to-day activities or any plan that requires someforesight and organization.

366/800

SHORT-TERM MEMORY Score Received: 400

Jeff has obtained a score in short-term memory below of what is expected for their age,which is compatible with moderate cognitive decline associated with Chemo-Fog. Short-term memory is the ability to keep a small amount of information for a short period oftime, such as when we retain the beginning of a sentence to understand it as a whole. Aproblem in short-term memory may alter the understanding of what we hear, by notproperly retaining the information that comes to our senses. According to the latestresearch shows that patients after a cancer process observe a poorer functioning inshort-term memory

WORKING MEMORY Score Received: 331

Jeff has obtained a score in working memory below of what is expected for their age,which is compatible with moderate cognitive decline. Usually, patients following acancer process verbalize a decline in working memory, which is the ability to retain andmanipulate information necessary for complex cognitive tasks, such ascomprehension, learning, and reasoning. A de ciency in working memory may meandi culty remembering daily tasks, appointments or turning off the light before leavinghome. T he neurotoxicity of the drugs used in cancer processes, stress and anxietyseem to justify this decline in working memory in cancer patients.

IN DETAIL: COGNITIVE AREAS ASSOCIATED WITH THECHEMO-FOG EFFECT

REASONING

MEMORY

642

80 0

400

80 0

331

80 0




576/800

FOCUSED ATTENTION Score Received: 529

Jeff has obtained scores that indicate that focused attention is appropriate for his age,so it is not a cognitive indicator associated with the Chemo-Fog effect. Focusedattention can be de ned as the ability of our brain to focus our attention on an objectivestimulus, regardless of how long it lasts. Lack of attention and concentration problemsare often described by patients who have cognitive impairment following an oncologicalprocess. T his attentional de cit in uences everyday activities such as reading a book,following a conversation or watching a T V program.

UPDATING Score Received: 622

Jeff has obtained a score in updating appropriate for their age, so it is not a cognitiveindicator associated with the Chemo-Fog effect. Cognitive updating can be de ned asthe ability to monitor the behavior we conduct and make sure that it complies with theprepared action plan.

520/800

RESPONSE TIME Score Received: 520

Jeff has obtained a score in response time appropriate for their age, so it is not anindicator of cognitive decline. Response time is the ability to perceive and process asimple stimulus and respond to it, such as answering a speci c question. People whohave undergone an oncological process and verbalize having cognitive di culties referto a "mental nebula" as if it were slow to think or think clearly, this manifests itself in aslow response time because it is likely that they have more di culties to giveresponses in an agile and fluid way.

ATTENTION

COORDINATION

529

80 0

622

80 0

520

80 0




296/800

RECOGNITION Score Received: 296

Jeff has obtained a score in recognition below of what is expected for their age. T hismight be indicator associated with moderate cognitive decline. Recognition can bede ned as the ability of our brain to identify the stimuli we have previously perceived(situations, people, objects, etc.). Recognition and other visual disturbances have beendescribed as possible cognitive sequelae of chemotherapy and the cancer process,which can affect reading, driving and other daily activities.

PERCEPTION

296

80 0




WORKING MEMORYHas trouble rememberinginformation if abbreviat ions andacronyms are not used

Forgets what they were saying if theyare interrupted.

PLANNINGCalculates t ime and steps requiredfor a task.

Knows easily how to start doing atask.

FOCUSED ATTENTIONIs able to concentrate withoutproblems and not get distractedeasily.

Completes things you have to doquickly and efficient ly.

UPDATINGReviews their act ions and take careof the details.

Is able to detect and correctmistakes.

EXECUTIVE FUNCTIONS IN THE CHEMO-FOG EFFECT

Executive functions are a set of sophisticated cognitive skills that make our behavior purposeful.According to the description, we found that the cognitive abilities most affected by the Chemo-Fogeffect are the executive functions such as planning, work memory, focused attention and updatingamong others

IT IS POSSIBLE THAT JEFF:




LOW RISK

EXECUTIVE FUNCTIONASSESSMENT FOR JEFF

The oncological process and the ef fects of medication can lead to a possible declinein some executive functions. Jef f has obtained executive function indices that indicatethat these abilities are appropriate for their age, so it is not an indicator of a cognitivepro le compatible with cognitive decline. Jef f 's strongest areas in the executivefunctions are planning, focused attention and updating, while working memory is anarea of improvement. This is why we recommend that you provide this information to aprofessional to help make a more precise diagnosis.


JEFF'S PROFILE


Working Memory

Planning

Focused Attention

Updating




03CONCLUSIONSJeff has responded a rmatively to an exclusion criterion for the Chemo-Fog effect, which meansthat differential diagnosis and co-morbidity must be established with other possible disorders bya quali ed professional (psychologist, psychiatrist or neuro logist). This criterion may exclude thepossibility of suffering from symptoms associated with the cancer process.

It is e sse nt ia l t ha t a qua lif ie d prof e ssiona l (psychia t rist , psychologist ,ne uropsychologist ) e st a blish t he dia gnosis t a king int o a ccount t he e xclusion crit e riaa nswe re d by Je f f in t he que st ionna ire :

Has not had cancer in the last three years.

In addition to the interpretation of symptoms and cognitive pro le assessed, the fo llowingcriteria should be taken into account to ensure the validity of the diagnosis by a quali edprofessional:

Ge ne ra l crit e ria f rom t he que st ionna ire t ha t Je f f re sponde d YES t o:

Frequently uses a tablet or touchscreen.Didn't used to feel like sad, dejected, or apathetic, and has been feeling like this for morethan two weeks.Has had cancer at some point in their life.T heir body is free from substances (medicine or drugs) that may cause these cognitivechanges and/or difficulties.Frequently uses a computer mouse.Is right-handed.Has received hormone or chemo therapy.

Ge ne ra l crit e ria f rom t he que st ionna ire t ha t Je f f re sponde d NO t o:

Uses glasses or contact lenses.T his lack of concentration, impulsiveness, and restlessness are sporadic.Has had cancer in the last three years.Uses hearing aids.

CONCLUSIONS

Due to the answers provided in the questionnaire, it is necessary to establish a differential diagnosis and co-morbiditywith other possible disorders by a qualified professional (psychologist, psychiatrist or neurologist).

We recommend that you review why Jeff shows symptoms compatible with Chemo-Fog by studying the co-morbiditywith other diseases or other causes.

Use this code to get a 25% on the clinical brain training program: Chemo -Fo g

Please be sure that all of the questions have been answered carefully and correctly, and that the assessment wascompleted in a quiet room free from distractions, as this may alter results. T he data in this report corresponds to aspecific time in Jeff's life and may vary over time.

COMMENTS



Documents

DIAGNOSTIC TEST CAB-CF COGNITIVE CHEMO FOG · The CAB-CF is a scientiAc resource that makes it possible to evaluate the risk index of suffering from Chemo-Fog effect during the oncology